HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- CMS proposes expanded coverage of clinical trials
-
- Erik Adolf von Willebrand: 1870-1949
- Dalteparin is treatment of choice for cancer patients with VTE Jeffrey Weitz, MD
- Optimizing communication between cancer patients and oncology medical teams Maurie Markman, MD
- FDA panel rejects mifamurtide for osteosarcoma in children
- FDA panel votes to restrict erythropoiesis-stimulating agents
- Training, faculty morale factors in career path Mark Klein, MD
- Biomarkers with lapatinib could predict breast cancer response to treatment
- HPV vaccine efficacy remains high according to results 2.4 years later
-
- Dexrazoxane for anthracycline extravasations well-tolerated Lisa K. Lohr, PharmD, BCPS, BCOP